Salvia divinorum
Stats & Data
Sally
Sally d
Magic mint
Seer's sage
Diviner's sage
Psychoactive Class
Psychedelic
Effect Profile
Curated
+ 2,569 Reports
Strong visuals with moderate auditory effects, low headspace
Body Load / Somatic Effects×1
03.3
Catalog
BlueLight
Duration Timeline
Bluelight
Onset
Comeup
Peak
Offset
After Effects
Smoked (Dried Leaf)
0-1 minutes
4-19 minutes
10-30 minutes
15 minutes - 1.0 hours
Smoked (5X Extract)
0-1 minutes
4-19 minutes
10-30 minutes
15 minutes - 1.0 hours
Smoked (10X Extract)
0-1 minutes
4-19 minutes
10-30 minutes
15 minutes - 1.0 hours
Sublingual/Quid (Fresh Leaf)
10-19 minutes
30 minutes - 1.0 hours
30 minutes - 1.5 hours
1-2 hours
Sublingual/Quid (Dried Leaf)
10-19 minutes
30 minutes - 1.0 hours
30 minutes - 1.5 hours
1-2 hours
Vaporized (Pure Salvinorin A)
0-1 minutes
1-10 minutes
10-19 minutes
15 minutes - 1.0 hours
Empirical Duration
Erowid Reports
Onset
Come Up
Peak
Offset
Community Effects
TripSit
Positive
euphoria
visual enhancement
mood lift
dissociation
Experience Report Analysis
Erowid
BlueLight
2,197
Reports
1995–2025
Date Range
503
With Age Data
31
Effects Detected
Effect Analysis
Erowid + Bluelight
Effects aggregated from
2,247 experience reports
(2,197 Erowid + 372 Bluelight)
2,247
Reports
139
Effects Detected
42
Positive
62
Adverse
35
Neutral
Effect Sentiment Distribution
Positive Effects 42
Color Enhancement
32.7%
83%
Awe
30.0%
83%
Music Enhancement
28.1%
70%
Geometric Imagery
28.0%
88%
Tactile Enhancement
26.2%
85%
Empathy
22.0%
85%
Stimulation
20.0%
76%
Euphoria
19.6%
87%
Focus Enhancement
18.5%
70%
Introspection
16.3%
82%
Insight
12.0%
83%
Mystical Quality
10.0%
87%
Joy
10.0%
87%
Wonder
10.0%
83%
Body High
9.1%
84%
Fractal Imagery
8.0%
89%
Contentment
8.0%
80%
Peace
8.0%
88%
Visual Trails
6.0%
82%
Bliss
6.0%
85%
Adverse Effects 62
Fear
62.0%
89%
Anxiety
51.9%
84%
Thought Disorganization
50.0%
81%
Depersonalization
48.0%
84%
Body Load
38.0%
77%
Confusion
37.0%
87%
Entity Imagery
32.0%
87%
Panic
30.0%
89%
Scene Replacement
20.0%
90%
Environmental Transfiguration
18.0%
85%
Body Distortion
18.0%
90%
Memory Suppression
16.3%
81%
Temporal Disorientation
16.0%
85%
Derealization
12.0%
88%
Ataxia
10.0%
78%
Heaviness
10.0%
81%
Time Looping
10.0%
88%
Delusion
10.0%
85%
Motor Impairment
8.1%
79%
Sweating
8.0%
82%
Dose-Response Correlation
How effect frequency changes across dose levels
View data table
| Effect |
Threshold (n=381) |
| Anxiety |
53.5%
|
| Visual Distortions |
50.9%
|
| Confusion |
42.0%
|
| Color Enhancement |
31.5%
|
| Music Enhancement |
28.9%
|
| Tactile Enhancement |
27.6%
|
| Closed-Eye Visuals |
25.7%
|
| Empathy |
24.4%
|
| Dissociation |
22.8%
|
| Auditory Effects |
22.8%
|
| Euphoria |
22.6%
|
| Focus Enhancement |
19.7%
|
| Stimulation |
18.6%
|
| Introspection |
18.6%
|
| Memory Suppression |
17.6%
|
Subjective Effect Ontology
Experience Reports
Structured effect tags extracted from 2,569
Erowid & Bluelight experience reports
using a controlled vocabulary of 220+ canonical effects across 15 domains.
Auditory
music enhancement
617
28.1%
auditory effects
496
19.8%
Cognitive
confusion
831
36.4%
focus enhancement
406
18.5%
introspection
367
17.0%
memory suppression
366
17.7%
Emotional
anxiety
1167
50.9%
empathy
495
19.5%
euphoria
441
18.7%
Motor
stimulation
450
18.5%
sedation
194
8.3%
motor impairment
183
11.6%
Selfhood
dissociation
508
21.0%
ego dissolution
201
12.6%
Somatic
body high
204
8.9%
sweating
180
8.0%
Tactile
tactile enhancement
588
23.1%
Temporal
time distortion
238
10.0%
Visual
visual distortions
1022
41.5%
color enhancement
735
30.6%
closed eye visuals
506
23.2%
open eye visuals
255
11.2%
22 unique effects extracted
· Derived from
Erowid & Bluelight reports
Dose–Effect Mapping
Experience Reports
How reported effects shift across dose tiers, based on
2197 experience reports.
Limited tier coverage — most reports fall within the
Threshold range.
Effects at other dose levels may not be represented.
| Effect |
Threshold
(n=381)
|
|
| anxiety |
|
|
| visual distortions |
|
|
| confusion |
|
|
| color enhancement |
|
|
| music enhancement |
|
|
| tactile enhancement |
|
|
| closed-eye visuals |
|
|
| empathy |
|
|
| dissociation |
|
|
| auditory effects |
|
|
| euphoria |
|
|
| focus enhancement |
|
|
| stimulation |
|
|
| introspection |
|
|
| memory suppression |
|
|
| open-eye visuals |
|
|
| time distortion |
|
|
| sweating |
|
|
| body high |
|
|
| motor impairment |
|
|
Showing top 20 of 34 effects
Dosage Distribution
Dose distribution from experience reports
Median: 200.0 mg
IQR: 100.0–400.0 mg
n=378
Real-World Dose Distribution
62K Doses
From 2294 individual dose entries
Sublingual (n=39)
Median: 2000.0mg
25th: 250.0mg
75th: 4425.0mg
90th: 6800.0mg
mg/kg median: 39.193
mg/kg 75th: 83.0
Smoked (n=501)
Median: 166.0mg
25th: 100.0mg
75th: 330.0mg
90th: 500.0mg
mg/kg median: 2.45
mg/kg 75th: 5.125
Oral (n=7)
Median: 1000.0mg
25th: 500.0mg
75th: 1750.0mg
90th: 5500.0mg
mg/kg median: 15.204
mg/kg 75th: 23.322
Common Combinations
Most co-occurring substances in experience reports
Form / Preparation
Most common forms and preparations reported
Body-Weight Dosing
Dose relative to body weight from reports with weight data
Smoked
Median: 2.594 mg/kg
IQR: 1.297–5.513 mg/kg
n=363
Oral
Median: 15.198 mg/kg
IQR: 7.353–29.002 mg/kg
n=8
Unknown
Median: 62.972 mg/kg
IQR: 33.389–133.333 mg/kg
n=17
Sublingual
Median: 0.053 mg/kg
IQR: 0.027–24.958 mg/kg
n=15
Redose Patterns
Redosing behavior across 2027 reports
9.9%
Redosed
1.1
Avg Doses
14m
Median Interval
← Back to Salvia divinorum